BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27015966)

  • 41. Therapy-refractory panic: current research areas as possible perspectives in the treatment of anxiety.
    Diemer J; Vennewald N; Domschke K; Zwanzger P
    Eur Arch Psychiatry Clin Neurosci; 2010 Nov; 260 Suppl 2():S127-31. PubMed ID: 20936296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anxiety sensitivity risk reduction in smokers: A randomized control trial examining effects on panic.
    Schmidt NB; Raines AM; Allan NP; Zvolensky MJ
    Behav Res Ther; 2016 Feb; 77():138-46. PubMed ID: 26752327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. D-cycloserine augmentation of cognitive behavioral therapy for delusions: A randomized clinical trial.
    Diminich ED; Dickerson F; Bello I; Cather C; Kingdon D; Rakhshan Rouhakhtar PJ; Hart KL; Li C; Troxel AB; Goff DC
    Schizophr Res; 2020 Aug; 222():145-152. PubMed ID: 32591238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission.
    McGuire JF; Wu MS; Piacentini J; McCracken JT; Storch EA
    J Clin Psychiatry; 2017 Feb; 78(2):196-206. PubMed ID: 27314661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive-behavioral therapy and the treatment of panic disorder: efficacy and strategies.
    Otto MW; Deveney C
    J Clin Psychiatry; 2005; 66 Suppl 4():28-32. PubMed ID: 15842185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of an Internet-based intervention with self-applied exposure therapy in virtual reality for people with panic disorder: study protocol for a randomized controlled trial.
    Schultz J; Baumeister A; Schmotz S; Moritz S; Jelinek L
    Trials; 2023 Aug; 24(1):521. PubMed ID: 37573377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation.
    Santa Ana EJ; Rounsaville BJ; Frankforter TL; Nich C; Babuscio T; Poling J; Gonsai K; Hill KP; Carroll KM
    Drug Alcohol Depend; 2009 Oct; 104(3):220-7. PubMed ID: 19592176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D-Cycloserine augmentation of cognitive behavior therapy for pediatric OCD: Predictors and moderators of outcome.
    Wilhelm S; Berman N; Small BJ; Porth R; Storch EA; Geller D
    J Affect Disord; 2018 Dec; 241():454-460. PubMed ID: 30149332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.
    Levinson CA; Rodebaugh TL; Fewell L; Kass AE; Riley EN; Stark L; McCallum K; Lenze EJ
    J Clin Psychiatry; 2015 Jun; 76(6):e787-93. PubMed ID: 26132687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sudden gains in exposure-focused cognitive-behavioral group therapy for panic disorder.
    Nogueira-Arjona R; Santacana M; Montoro M; Rosado S; Guillamat R; Vallès V; Fullana MA
    Clin Psychol Psychother; 2017 Nov; 24(6):1285-1291. PubMed ID: 28493541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nicotine deprivation attenuates panic reactivity in smokers: Findings from a placebo-controlled nicotine patch study.
    Abrams K; Krimmel S; Johnson S; Cieslowski K; Strnad H; Melum A; Kryder C
    Depress Anxiety; 2017 Nov; 34(11):996-1005. PubMed ID: 28489321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Panic attack history and anxiety sensitivity in relation to cognitive-based smoking processes among treatment-seeking daily smokers.
    Johnson KA; Farris SG; Schmidt NB; Smits JA; Zvolensky MJ
    Nicotine Tob Res; 2013 Jan; 15(1):1-10. PubMed ID: 22544839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
    Norberg MM; Krystal JH; Tolin DF
    Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced exposure therapy for combat-related Posttraumatic Stress Disorder (PTSD): Study protocol for a randomized controlled trial.
    Difede J; Rothbaum BO; Rizzo AA; Wyka K; Spielman L; Jovanovic T; Reist C; Roy MJ; Norrholm SD; Glatt C; Lee F
    Contemp Clin Trials; 2019 Dec; 87():105857. PubMed ID: 31669451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. D-cycloserine enhances generalization of fear extinction in children.
    Byrne SP; Rapee RM; Richardson R; Malhi GS; Jones M; Hudson JL
    Depress Anxiety; 2015 Jun; 32(6):408-14. PubMed ID: 25775435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
    Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
    JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Panic attacks and smoking cessation among cancer patients receiving smoking cessation treatment.
    Farris SG; Robinson JD; Zvolensky MJ; Hogan J; Rabius V; Cinciripini PM; Karam-Hage M; Blalock JA
    Addict Behav; 2016 Oct; 61():32-9. PubMed ID: 27235990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
    Storch EA; Murphy TK; Goodman WK; Geffken GR; Lewin AB; Henin A; Micco JA; Sprich S; Wilhelm S; Bengtson M; Geller DA
    Biol Psychiatry; 2010 Dec; 68(11):1073-6. PubMed ID: 20817153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The research network PANIC-NET: improving the treatment of panic disorder - from a better understanding of fear circuit mechanisms to more effective psychological treatment and routine care].
    Arolt V; Zwanzger P; Ströhle A; Hamm A; Gerlach A; Kircher T; Deckert J
    Psychother Psychosom Med Psychol; 2009; 59(3-4):124-31. PubMed ID: 19350472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence.
    Prisciandaro JJ; Myrick H; Henderson S; McRae-Clark AL; Santa Ana EJ; Saladin ME; Brady KT
    Drug Alcohol Depend; 2013 Sep; 132(1-2):195-201. PubMed ID: 23497788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.